DELTAREX-G EXPANDS USFDA AUTHORIZED ACCESS TO BREAST CANCER, PANCREAS CANCER, OSTEOSARCOMA & SOFT TISSUE SARCOMA

August 03, 2023 11:00 PM AEST | By EIN Presswire

Google News:

DELTAREX-G EXPANDS USFDA AUTHORIZED ACCESS TO BREAST CANCER, PANCREAS CANCER, OSTEOSARCOMA & SOFT TISSUE SARCOMA — Image source: EIN Presswire

Recent News

Carney launches ‘One Canadian Economy’ Act to unify trade, approvals

Trump signs orders to enhance drone defenses, support supersonic trave...

US job growth in May tops forecasts, but Macquarie warns cracks are em...

U.S. Treasury, Commerce secretaries and Trade Representative to meet C...

LOS ANGELES, CALIFORNIA, UNITED STATES OF AMERICA, August 3, 2023/EINPresswire.com/ -- The Aveni Foundation and the Cancer Center of Southern California/Sarcoma Oncology Center are proud to announce that DeltaRex-G has gained USFDA authorization to expand access to an intermediate size population of advanced breast cancer, in addition to pancreatic cancer, osteosarcoma and soft tissue sarcoma which was originally authorized in 2020. Further, DeltaRex-G may now be given with other FDA approved cancer drugs for these cancer types.

Children as young as 12 years of age with advanced osteosarcoma and soft tissue sarcoma may receive DeltaRex-G with other cancer drugs at pediatric dosing schedules. Unlike chemotherapy, there are few, if any, side effects with this drug.

The human cyclin G1 (CCNG1) is a cancer gene that is found in all tumor types that have been tested to date. DeltaRex-G is a gene-targeted cancer drug with a navigational system that delivers the medicine directly to tumors and carries a CCNG1 inhibitor as its genetic payload to kill cancer cells and their blood supply without collateral damage.

There are long term (>10 years) cancer survivors with DeltaRex-G therapy, giving rise to research on how DeltaRex-G could eradicate cancer stem cells that are responsible for recurrence and the spread of cancer to other organs.

DeltaRex-G is supplied by the Aveni Foundation, an IRS approved 501(c)(3) public charity founded by Dr. Gordon in 2018. Aveni Foundation raises funds through generous donations from benefactors to make the medicine. It is not available through drug or insurance companies.

To donate: Click on the DONATE button at www.avenifoundation.org or send a check to Aveni Foundation, 2811 Wilshire Blvd., Suite 420, Santa Monica CA 90403.

For further information, please visit our websites: www.avenifoundation.org, or contact Dr. Gordon at [email protected] or [email protected].

ERLINDA GORDON
Aveni Foundation
+1 818-726-3278
email us here

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.